Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001522780-26-000007

Director sold 12,567 shares at an average $32.03 ($402,528)

  • Director acquired 26,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kaye Edward M. MD · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-14 Exercise or conversion : show line 1 in the form +26,250 137,124 D
2026-08-18 Sale : show line 2 in the form −11,930 $32.01 $381,846 125,194 D
2026-08-18 Sale : show line 3 in the form −637 $32.47 $20,682 124,557 D
Open-market sales · 12,567 sh · avg $32.03 · $402,528

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-14 Exercise or conversion : show line 4 in the form Performance Stock Units −26,250 0 D
Loading xslF345X06/form4-08192026_120851.xml…